Results 1 to 10 of about 57,560 (274)

Assessment of antimycobacterial activities of pure compounds extracted from Thai medicinal plants against clarithromycin-resistant Mycobacterium abscessus [PDF]

open access: yesPeerJ, 2021
Background Infection with Mycobacterium abscessus is usually chronic and is associated with clarithromycin resistance. Increasing drug resistance is a major public-health problem and has led to the search for new antimycobacterial agents.
Auttawit Sirichoat   +6 more
doaj   +2 more sources

Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection [PDF]

open access: yes, 1998
In this randomized, multicenter trial, we evaluated the effectiveness and side effect profile of a modified omeprazole-based triple therapy to cure Helicobacter pylori infection.
Miehlke, Stephan   +11 more
core   +1 more source

Primary Ciliary Dyskinesia that Responded to Long-Term, Low-Dose Clarithromycin [PDF]

open access: yes, 2010
A 46-year-old man was referred to our hospital with hemoptysis. He had been diagnosed with chronic sinusitis since childhood, but had received no treatment. Chest CT showed a diffuse centrilobular granular shadow and thickened bronchial walls.
Kakugawa, Tomoyuki   +15 more
core   +1 more source

Lectin-conjugated microspheres for eradication of Helicobacter pylori infection and interaction with mucus [PDF]

open access: yes, 2014
Using second generation mucoadhesives may enhance targeting antibiotics for eradication of Helicobacter pylori from the stomach for the treatment of peptic ulcer.
Conway, Barbara R   +2 more
core   +1 more source

Effect of Clarithromycin on the Pharmacokinetics of Cabergoline in Healthy Controls and in Patients With Parkinson’s Disease

open access: yesJournal of Pharmacological Sciences, 2006
.: Cabergoline is used in the treatment of Parkinson’s disease (PD). Clarithromycin is a potent inhibitor of CYP3A4 and P-glycoprotein and is often co-administered with cabergoline in usual clinical practice.
Akiko Nakatsuka   +7 more
doaj   +1 more source

Effective Eradication Regimen and Duration According to the Clarithromycin Susceptibility of Helicobacter pylori Determined Using Dual Priming Oligonucleotide-Based Multiplex Polymerase Chain Reaction

open access: yesGut and Liver, 2023
Background/Aims: Dual priming oligonucleotide-based multiplex polymerase chain reaction (DPO-PCR) has recently been used for both the detection of Helicobacter pylori and the identification of H.
Soo-Young Na   +4 more
doaj   +1 more source

Efficacy of clarithromycin against experimentally induced pneumonia caused by clarithromycin-resistant Haemophilus influenzae in mice. [PDF]

open access: yes, 2010
Clarithromycin is a 14-member lactone ring macrolide with potent activity against Haemophilus influenzae, including ampicillin-resistant strains. We evaluated the in vivo efficacy of clarithromycin at 40 mg/day and 100 mg/day for 3 days in the treatment ...
Araki, Nobuko   +10 more
core   +1 more source

Effect of Clarithromycin on Enhancement of Doxorubicin-induced Cytotoxicity and Apoptosis in A549 Tumor-Cell Line

open access: yesJournal of Mazandaran University of Medical Sciences, 2022
Background and purpose: Nowadays, multi-drug regimens or combination therapy are new approaches in cancer treatment that combine two or several therapeutic agents.
Mohammad Shokrzadeh   +2 more
doaj  

Clarithromycin resistance and 23S rRNA gene point mutations of Helicobacter pylori infection in children

open access: yesThe Turkish Journal of Pediatrics, 2016
This study aims to evaluate Helicobacter pylori with clarithromycin resistant genotypes in Manisa region, Turkey. Two hundred patients, who received diagnosis of Helicobacter pylori infection histopathologically, were included.
Yeliz Çağan-Appak   +5 more
doaj   +1 more source

Therapeutic efficacy of macrolides in management of patients with mild COVID-19

open access: yesScientific Reports, 2021
Evidence on the efficacy of adding macrolides (azithromycin or clarithromycin) to the treatment regimen for COVID-19 is limited. We testify whether adding azithromycin or clarithromycin to a standard of care regimen was superior to standard of supportive
Alaa Rashad   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy